| ARE | Antioxidant response element |
| AT II | Angiotensin II |
| ATP III | National Cholesterol Education Program’s Adult Treatment Panel III report |
| BMI | Body mass index |
| CAT | Catalase |
| CD36 | Cluster determinant 36 |
| CD38 | Cluster of differentiation 38 |
| CETP | Cholesterol ester transport protein |
| CHD | Coronary heart disease |
| Cmax | Maximum concentration |
| CVD | Cardiovascular diseases |
| EGIR | European Group for the Study of Insulin Resistance |
| FFA | Free fatty acids |
| GPX | Glutathione peroxidase |
| GSH | Glutathione |
| HDL | High-density lipoproteins |
| HF | Heart failure |
| I/R | Ischaemia/reperfusion |
| IDF | International Diabetes Federation |
| IL | Interleukin |
| IL-6 | Interleukin 6 |
| ISO | Isoproterenol |
| Keap1 | Kelch-like ECH-associated protein 1 |
| LDL | Low-density lipoproteins |
| M1 | Macrophages 1 |
| M2 | Macrophages 2 |
| MRP | Multidrug resistance proteins |
| MW | Molecular weight |
| NAD | Nicotinamide adenine dinucleotide |
| NF-kB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NHANES | National Health and Nutritional Examination Survey |
| NO | Nitric oxide |
| NAFLD | Non-alcoholic Fatty Liver Disease |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| PPARγ | Peroxisomes proliferator activated receptor gamma |
| SIRT1 | Sirtuin-1 |
| SOD | Superoxide dismutase |
| STAT 3 | Signal transducer and activator of transcription 3 |
| TGs | Triglycerides |
| TNF | Tumour Necrosis factor |
| TXNRD | Thioredoxin reductase |
| VLDL | Very low-density lipoproteins |
| VO | Visceral obesity |
| WHO | World Health Organization |